Wearable Heart Rate Accuracy in Clinical Trials is more than a technical specification; it is a cornerstone...
Digital Health
Securing FDA approval for a low-cost digital therapeutics (DTx) platform is a formidable but achievable goal. By...
AI‑driven digital biomarkers promise to transform patient monitoring, early disease detection, and therapeutic decision‑making. However, turning a...
In 2024 the FDA’s Real‑World Evidence (RWE) program continues to expand, offering manufacturers a new pathway to...
Securing reimbursement for a digital therapeutic in the European Union requires more than meeting the Medical Device...